7XJ2

Structure of human TRPV3_G573S in complex with Trpvicin in C4 symmetry

7XJ2 の概要

• エントリーDOI: 10.2210/pdb7xj2/pdb
• EMDBエントリー: 33217
• 分子名称: Fusion protein of Transient receptor potential cation channel subfamily V member 3 and 3C-GFP, N-[5-[2-(2-cyanopropan-2-yl)pyridin-4-yl]-4-(trifluoromethyl)-1,3-thiazol-2-yl]-4,6-dimethoxy-pyrimidine-5-carboxamide (2 entities in total)
• 機能のキーワード: channel, membrane protein
• 由来する生物種: Homo sapiens (human); 詳細
• タンパク質・核酸の鎖数: 4
• 化学式量合計: 485375.42

構造登録者

Fan, J.,Yue, Z.,Jiang, D.,Lei, X. (登録日: 2022-04-14, 公開日: 2022-11-09, 最終更新日: 2025-07-02)

主引用文献

Fan, J.,Hu, L.,Yue, Z.,Liao, D.,Guo, F.,Ke, H.,Jiang, D.,Yang, Y.,Lei, X.
Structural basis of TRPV3 inhibition by an antagonist.
Nat.Chem.Biol., 19:81-90, 2023

PubMed Abstract: The TRPV3 channel plays vital roles in skin physiology. Dysfunction of TRPV3 causes skin diseases, including Olmsted syndrome. However, the lack of potent and selective inhibitors impedes the validation of TRPV3 as a therapeutic target. In this study, we identified Trpvicin as a potent and subtype-selective inhibitor of TRPV3. Trpvicin exhibits pharmacological potential in the inhibition of itch and hair loss in mouse models. Cryogenic electron microscopy structures of TRPV3 and the pathogenic G573S mutant complexed with Trpvicin reveal detailed ligand-binding sites, suggesting that Trpvicin inhibits the TRPV3 channel by stabilizing it in a closed state. Our G573S mutant structures demonstrate that the mutation causes a dilated pore, generating constitutive opening activity. Trpvicin accesses additional binding sites inside the central cavity of the G573S mutant to remodel the channel symmetry and block the channel. Together, our results provide mechanistic insights into the inhibition of TRPV3 by Trpvicin and support TRPV3-related drug development.

PubMed: 36302896
DOI: 10.1038/s41589-022-01166-5

実験手法

ELECTRON MICROSCOPY (3.64 Å)